详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Editorial: Linking cellular metabolism to hematological malignancies

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China. [2]Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Panchgaon (Manesar), Gurugram, Haryana-122413, India. [3]Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma, OK, United States. [4]Interdisciplinary Institute of Cancer Diagnosis and Treatment, Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, China.

出处：

DOI：

ISSN：

关键词： hematological malignancies cellular metabolism metabolic reprogramming immunometabolism drug resistance

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

最新[2023]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

第一作者：

第一作者机构： [1]Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China.

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications [2]Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma [3]Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies [4]Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition. [5]Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. [6]Untargeted and spatial-resolved metabolomics characterize serum and tissue-specific metabolic reprogramming in acute kidney injury [7]SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression [8]Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications [9]Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy [10]Nanomedicine Combats Drug Resistance in Lung Cancer